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data suggest that, although sense and antisense RNA mole-
cules might be expected to be equally toxic via their shared 
protein binding partners, distinct patterns of expression in 
various CNS neuronal populations could lead to relative 
differences in their contribution to the pathogenesis of neu-
ronal injury. Moreover in motor neurons, which are the pri-
mary target of pathology in ALS, the presence of antisense 
foci (χ2, p < 0.00001) but not sense foci (χ2, p = 0.75) 
correlated with mislocalisation of TDP-43, which is the 
hallmark of ALS neurodegeneration. This has implications 
for translational approaches to C9ORF72 disease, and fur-
thermore interacting RNA-processing factors and transcrip-
tional activators responsible for antisense versus sense tran-
scription might represent novel therapeutic targets.
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Introduction
GGGGCC hexanucleotide repeat expansions in C9ORF72 
represent the most common genetic variant of amyotrophic 
lateral sclerosis (ALS) and frontotemporal dementia (FTD) 
[7, 27]. The mechanism of pathogenesis is unknown, but 
it has been suggested that a gain-of-function toxicity may 
be mediated via sequestration of RNA recognition motif 
(RRM) containing proteins by RNA foci [2, 3]. It has been 
observed that RNA foci are formed, not only from sense, 
but also from antisense transcription of the repeat expan-
sion [7, 16, 21]. The relative contribution of GGGGCC-
repeat (sense) and CCCCGG-repeat (antisense) RNA mol-
ecules to disease pathogenesis is unknown, but is likely to 
have significant implications for subsequent translational 
Abstract GGGGCC repeat expansions of C9ORF72 rep-
resent the most common genetic variant of amyotrophic lat-
eral sclerosis (ALS) and frontotemporal dementia. We and 
others have proposed that RNA transcribed from the repeat 
sequence is toxic via sequestration of RNA-binding fac-
tors. Both GGGGCC-repeat (sense) and CCCCGG-repeat 
(antisense) molecules are detectable by fluorescence in situ 
hybridisation as RNA foci, but their relative expression 
pattern within the CNS and contribution to disease has not 
been determined. Blinded examination of CNS biosamples 
from ALS patients with a repeat expansion of C9ORF72 
showed that antisense foci are present at a significantly 
higher frequency in cerebellar Purkinje neurons and motor 
neurons, whereas sense foci are present at a significantly 
higher frequency in cerebellar granule neurons. Consistent 
with this, inclusions containing sense or antisense derived 
dipeptide repeat proteins were present at significantly 
higher frequency in cerebellar granule neurons or motor 
neurons, respectively. Immunohistochemistry and UV-
crosslinking studies showed that sense and antisense RNA 
molecules share similar interactions with SRSF2, hnRNP 
K, hnRNP A1, ALYREF, and hnRNP H/F. Together these 
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research. Work by Haeusler et al. [11] recently suggested 
that, with a small number of exceptions, the protein binding 
partners of the two species of RNA foci are similar.
Another suggested mechanism of pathogenesis is direct 
toxicity of one or more of five dipeptide repeat proteins 
(DPRs) translated in different reading frames from either 
the sense [23] or antisense [24] RNA molecules. Poly(Gly-
Ala) (GA) and poly(Gly-Arg) (GR) are translated from 
sense RNA molecules; poly(Pro-Ala) (PA) and poly(Pro-
Arg) (PR) are translated from the antisense RNA molecules 
and poly(Pro-Gly) (PG) is translated from both molecules. 
Several recent studies have described how these proteins 
might disrupt ribosomal RNA biogenesis and pre-mRNA 
splicing [15, 22] or form toxic aggregates [20]. If DPRs are 
key to pathogenesis, then aberrant nuclear export of repeat 
RNA sequences, which is necessary to facilitate access to 
cytoplasmic translation machinery, may be an attractive 
therapeutic target. We have previously identified interac-
tions between sense RNA repeat sequences and mRNA 
export adaptor proteins which might have a role in inappro-
priate licencing for nuclear export [3].
We conducted extensive immunohistochemistry (IHC) 
in tissue from C9ORF72-ALS cases to determine the dis-
tribution of each species of RNA foci within various CNS 
neuronal populations known to degenerate in C9ORF72-
disease [19]. Blinded examination of serial sections showed 
that antisense foci are present at a higher frequency in cer-
ebellar Purkinje neurons and motor neurons, whereas sense 
foci are present at a higher frequency in cerebellar granule 
neurons. Similar examination in neuronal populations of 
the hippocampal dentate gyrus and CA4 subfield did not 
reveal a consistent distinction, with significant variability 
between cases. Moreover, neuronal inclusions containing 
DPRs translated from sense RNA are present at a higher 
frequency in cerebellar granule neurons, whereas neu-
ronal inclusions containing DPRs translated from antisense 
RNA are present at a higher frequency in motor neurons. 
Notably, motor neurons are the primary target of pathol-
ogy in ALS. Furthermore we examined the distribution of 
RRM-containing proteins predicted to bind one or both of 
sense and antisense foci with specific attention to colocali-
sation with antisense RNA foci. Direct and specific bind-
ing to the antisense/sense repeat sequence was examined 
by UV crosslinking using purified recombinant proteins. 
Finally, we studied the relative association of each species 
of RNA foci with the hallmark of ALS neurodegenera-
tion, namely mislocalisation of TDP-43 in motor neurons 
[25]. We add novel insights to this field—in particular our 
focus on neuropathology has allowed us to contextualize 
the sense and antisense RNA foci within framework of the 
human disease.
Materials and methods
Human samples
This study was approved by the South Sheffield Research 
Ethics Committee and informed consent was obtained for 
all samples. Brain and spinal cord tissues were donated 
to the Sheffield Brain Tissue Bank for research, with the 
consent of the next of kin. IHC and RNA fluorescence in 
situ hybridisation (FISH) were performed on formalin fixed 
paraffin-embedded (FFPE) tissues from eight C9ORF72+ 
patients with ALS and/or FTD, three non-C9ORF72 ALS 
patients, and three neurologically normal controls. Clinical 
features of cases examined are summarized in Table 1.
RNA FISH
A 5′ TYE-563-labelled LNA (16-mer fluorescent)-incorpo-
rated DNA probe was used against the sense (Exiqon, Inc.; 
batch number 607323) and the antisense RNA hexanucleo-
tide repeat (Exiqon, Inc.; batch number 610331). Slides 
were prepared and RNA foci were visualised as described 
previously [3] using a Leica SP5 confocal microscope sys-
tem with a ×63/1.4 oil immersion objective lens. Briefly 
prehybridisation was followed by overnight hybridization 
Table 1  Clinical details of C9ORF72+ cases used in pathological analysis
Case numbers are matched in Tables 1, 2, and 3
Case Phenotype Sex (M/F) Age at onset (Years) Disease duration (Months) Site of onset Post-mortem delay (h)
1 ALS-FTD F 63 43 Cognitive 24
2 ALS F 56 43 Limb 32
3 ALS M 69 38 Limb ~96
4 ALS F 61 40 Bulbar 7
5 ALS F 58 7 Limb 2
6 ALS M 62 20 Bulbar ~48
7 ALS F 50 28 Bulbar 22
8 FTD F 58 36 Cognitive N/A
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at 66 °C in a humid atmosphere. A single wash at room 
temperature with 2 × SSC/0.1 % Tween-20 preceded three 
washes at 65 °C with 0.1 × SSC. Slides were then mounted 
in DAPI Vectashield or processed further for dual staining 
of RNA and protein.
RNA‑binding UV‑crosslinking assays
RNA-binding assays were carried out as described previ-
ously [12, 13]. Recombinant proteins were expressed and 
purified from E.coli (Supplementary Table 1). Magoh, 
SRSF2 9-101, ALYREF, hnRNP A1-like2, hnRNP K, and 
hnRNP F were expressed in E. coli and purified by Ion 
Metal Affinity Chromatography in 1 M NaCl containing 
buffers to remove potentially bound RNA from E. coli. 
hnRNP K was further purified by ion exchange chromatog-
raphy using a Mono Q column (GE healthcare).
(GGCCCC)5 and (CCCCGG)5 RNAs were 5′ end 
labelled with [ɣ32P]-ATP using T4 polynucleotide kinase 
(Fermentas). Reaction mixes were made up in RNA bind-
ing buffer [15 mM HEPES pH 7.5, 500 mM NaCl, 5 mM 
MgCl2, 10 % (v/v) glycerol, 0.05 % (v/v) Tween-20] with 
50 ng radiolabelled RNA and 2 µg purified recombinant 
protein. Mixes were incubated for 10 min at room tem-
perature before being UV irradiated on ice at full power. 
Complexes were analysed by SDS/PAGE and stained with 
Coomassie blue before being vacuum dried and exposed on 
a phosphoimage screen.
Immunohistochemistry
The following antibodies were used for IHC anti-TDP-43 
(Proteintech 10782-2-AP), anti-hnRNP H/F (Abcam 
ab10689), anti-hnRNP A1 (Abcam ab5832, 9H10 clone), 
anti-SRSF2 (Abcam ab11826), anti-ALYREF (Sigma, 
clone 11G5), anti-nucleolin (Proteintech 10556-1-AP), and 
anti-hnRNP K (Abcam ab52600). Poly-GA was detected 
with anti-GA antibodies (mouse, clone 5F2) as previously 
described [18]. Poly-GR, poly-PA, poly-PR, and poly-PG 
were detected with antibodies provided by Stuart Picker-
ing-Brown (Proteintech, Manchester, UK). For anti-hnRNP 
A1 and anti-SRSF2, antigen retrieval was performed by 
microwaving for 10–30 min in EDTA at pH 8.0. For all 
other antibodies, antigen retrieval involved 10–20 min 
microwave in trisodium citrate at pH 6.5 except for anti-
hnRNP H/F where no specific antigen retrieval was per-
formed. After incubation with the primary antibodies over-
night at 4 °C in DEPC-treated PBS/5 % BSA slides were 
washed in DEPC PBS and incubated in fluorescent species-
specific secondary antibodies. When dual staining of pro-
tein and RNA was performed, RNA FISH was performed 
first after which slides were immediately transferred to 
PBS/5 % BSA for protein staining.
Results
Relative distribution of sense and antisense RNA foci
The frequency of sense and antisense RNA foci was determined 
in five neuronal populations: Purkinje and granule neurons in 
the cerebellum, motor neurons of the spinal cord ventral horn, 
and neurons of the hippocampal dentate gyrus and CA4 sub-
field. These neuronal populations were chosen as they all exhibit 
neurodegeneration in C9ORF72-ALS and are characteristic of 
both motor (motor neurons) and extra-motor (cerebellum and 
hippocampus) pathology [4]. Sequential sections of tissue from 
C9ORF72-ALS cases, non-C9ORF72 ALS cases, and controls 
were examined for RNA foci in a blinded manner. No RNA foci 
were observed in tissue from controls and non-C9ORF72 ALS 
cases. Forty Purkinje neurons, forty motor neurons, >200 gran-
ule neurons, >150 dentate gyrus neurons, and >100 CA4 sub-
field neurons were evaluated from four C9ORF72+ ALS and/
or FTD cases. The average frequency of sense and antisense 
foci per cell is shown in Table 2 (raw data are shown in Sup-
plementary Table 2). Comparison between cases showed that 
the frequency of sense and antisense RNA foci was positively 
correlated in all neuronal populations i.e., cases with more sense 
foci per cell also had more antisense foci per cell. The exception 
to this was the dentate gyrus neurons where case-to-case vari-
ability was smallest (Pearson correlation coefficient: cerebellar 
Purkinje neurons 0.99, cerebellar granule neurons 0.6, motor 
neurons 0.2, CA4 subfield neurons 0.65) (Table 2). In the cere-
bellar populations and motor neurons but not hippocampal neu-
rons, there was a difference between the frequency of antisense 
and sense foci which was consistent between cases (representa-
tive images are shown in Fig. 1a). To determine whether this dif-
ference was statistically significant, the foci count was modelled 
as a Poisson distribution and performing a likelihood-ratio test 
revealed that, within each individual case, the frequency of anti-
sense compared to sense RNA foci was significantly higher in 
Purkinje neurons (likelihood-ratio test p < 0.05) and motor neu-
rons (likelihood-ratio test p < 0.05), but significantly lower in 
cerebellar granule neurons (likelihood-ratio test p < 0.05). The 
fact that sense and antisense foci were relatively more abundant 
in different neuronal populations is against an artefact caused by 
differences in affinity of RNA FISH probes.
As reported for sense RNA foci [3], we observed cyto-
plasmic antisense RNA foci even in post-mitotic mature 
cells such as motor neurons (Fig. 1b).
Relative distribution of DPRs derived from sense 
and antisense RNA sequences
Staining of poly-GA, poly-GR, poly-PA, poly-PR, and 
poly-PG protein was studied in cerebellar granule neurons 
and motor neurons from three C9ORF72-ALS cases. More 
than 1000 granule neurons and approximately 50 motor 
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neurons were examined in a blinded experiment. Neuronal 
inclusions containing sense RNA derived DPRs were only 
observed in granule neurons, whereas inclusions contain-
ing antisense RNA derived DPRs were only observed in 
motor neurons (Fig. 2a). Above background staining for 
poly-PG was not observed in any cells. In motor neurons, 
inclusions were predominantly nuclear, but in granule neu-
rons inclusions were predominantly cytoplasmic (Fig. 2a). 
Background staining was examined in control and non-
C9ORF72-ALS cases.
As a further validation, and to extend, the conclusions 
of this study to a larger number of cases, dual staining of 
poly-GA, and poly-PA protein were examined in a further 
blinded experiment. Approximately 1000 granule neurons 
and 50 motor neurons were studied from six C9ORF72+ 
ALS and/or FTD cases including three cases not utilized in 
the earlier analysis. In each case, the correct protein was 
determined based on the frequency of observed inclusions 
(Fig. 2b). Modelling the number of neuronal inclusions as 
a Poisson distribution and performing a likelihood-ratio 
test revealed that the frequency of poly-GA inclusions was 
significantly higher in granule neurons (likelihood-ratio 
test p < 0.01) and the frequency of poly-PA inclusions was 
significantly higher in motor neurons (likelihood-ratio test 
p < 0.01). The average frequencies of inclusions containing 
poly-GA and poly-PA protein are shown in Table 3 (raw 
data are shown in Supplementary Table 3).
In our previous study [3] we showed that, at a cellular 
level, there was no significant correlation between the pres-
ence of sense RNA foci and the presence of sense RNA-
derived poly-GA inclusions. In this study, we examined the 
relationship between the presence of antisense RNA foci 
and poly-PA inclusions in fifteen motor neurons from four 
C9ORF72-ALS cases (Supplementary Table 4). As for the 
sense species, there was no significant correlation between 
the two observations (χ2, p = 0.83).
Table 2  Mean and standard deviation (SD) of number of sense and antisense RNA foci per nucleus in Purkinje neurons, granule neurons, motor 
neurons, dentate gyrus neurons, and CA4 subfield neurons in four C9ORF72-ALS patients
In each case, antisense RNA foci are significantly more numerous in Purkinje neurons and motor neurons (likelihood-ratio test p < 0.05) but sig-
nificantly less numerous in granule neurons (likelihood-ratio test p < 0.05)
Case Antisense (mean) Antisense (SD) Sense (mean) Sense (SD) p value
Purkinje neurons
 1 26.40 20.3 6.40 17.4 2.37E−14
 2 4.30 4.19 1.10 2.18 0.002
 3 4.60 4.50 1.30 1.95 0.002
 4 6.30 5.54 1.40 1.51 6.88E−05
Granule neurons
 1 0.00 0.00 0.56 1.20 1.37E−12
 2 0.03 0.17 1.10 1.41 9.63E−18
 3 0.01 0.10 0.34 0.93 1.17E−07
 4 0.02 0.14 0.40 0.82 3.1E−07
Motor neurons
 1 14.90 24.5 1.50 1.65 5.65E−14
 2 3.00 4.06 1.00 1.25 0.02
 3 3.33 3.78 1.00 0.76 0.02
 4 5.40 6.52 2.44 3.40 0.02
Case Antisense (mean) Antisense (SD) Sense (mean) Sense (SD)
Dentate gyrus neurons
 1 0.65 1.90 0.88 2.34
 6 1.65 3.35 0.95 1.81
 7 0.89 2.42 1.39 2.23
 8 1.63 5.34 0.91 1.76
CA4 subfield neurons
 1 10.3 14.7 6.55 8.68
 6 3.17 6.51 1.33 1.67
 7 0.50 0.97 2.72 4.90
 8 6.31 10.8 9.82 13.8
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Cellular distribution of RNA foci and RRM‑containing 
proteins
We used confocal microscopy to validate in vivo some of 
the RRM-containing proteins that were found to interact 
with (CCCCGG)4 repeat RNA [11]. We and others have 
previously demonstrated colocalisation of SRSF2, hnRNP 
A1, hnRNP H/F, and ALYREF with sense RNA foci [3, 
17]. We set out to investigate the cellular distribution of the 
same proteins with respect to antisense RNA foci, and we 
also examined nucleolin and hnRNP K which are proposed 
to be specific binding partners of sense and antisense foci, 
respectively [11].
Approximately 50 cerebellar Purkinje neurons were 
examined in a blinded experiment, from a minimum of 
three C9ORF72-ALS cases. Simultaneous co-staining was 
carried out in parallel in non-C9ORF72 ALS cases and 
neurologically normal controls. For ALYREF, hnRNP A1, 
SRSF2, hnRNP H/F, and hnRNP K, the overall cellular dis-
tribution was not specifically altered in C9ORF72+ cases 
except for nuclear areas where colocalisation was demon-
strated (Fig. 3a–e). Haeusler et al. [11] observed disruption 
of nucleolin expression from the nucleolus in cell models 
expressing expanded C9ORF72, but reported a variable 
distribution or nucleolin in C9ORF72+ CNS tissue. In 
agreement with this, we identified C9ORF72+ neurons 
which did and did not demonstrate an altered distribution 
pattern of nucleolin (Fig. 3f).
By IHC, we demonstrated colocalisation of SRSF2, 
hnRNP A1, hnRNP H/F, ALYREF, and hnRNP K in cer-
ebellar Purkinje neurons with 34, 21, 3.4, 7.8, and 8.1 % 
of antisense RNA foci, respectively (Fig. 3a–e). In con-
trast, nucleolin was not observed to colocalise with anti-
sense RNA foci (Fig. 3f). To validate the IHC findings, we 
performed in vitro Ultra-Violet (UV) crosslinking assays 
using radiolabelled synthetic (GGGGCC)5 or (CCCCGG)5 
RNA oligonucleotides, and purified recombinant proteins 
synthesized in E.coli. Unlike IHC, this allows determina-
tion of direct and specific RNA:protein interactions via 
the formation of covalent bonds under UV light exposure. 
Both sense and antisense repeat RNA were observed to 
directly interact with hnRNP F, hnRNP A1, ALYREF, and 
Fig. 1  RNA FISH reveals the distribution of sense and antisense 
RNA foci in five neuronal populations. Representative images show 
that antisense RNA foci are more numerous in cerebellar Purkinje 
neurons and motor neurons; in contrast sense, RNA foci are more 
numerous in cerebellar granule neurons; neither population is more 
abundant in dentate gyrus neurons and CA4 subfield neurons of the 
hippocampus (a). Smaller foci are highlighted by arrowheads. As has 
been previously demonstrated for sense foci, antisense foci are occa-
sionally present in the cytoplasm of mature motor neurons (b, arrow-
head, the nuclear border is indicated by a dotted line). Scale bar 3 µm
▸
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SRSF2 proteins although the RNA-binding activity was 
not equal in all cases and for hnRNP A1 was relatively low 
(Fig. 4). In contrast, we failed to detect any direct interac-
tions between sense or antisense repeat RNA and hnRNP 
K, suggesting that the previously observed colocalisation 
of hnRNP K with antisense RNA foci is not due to direct 
binding between hnRNP K and CCCCGG-repeats. The 
smeared appearance of certain of the proteins on the phos-
pho image (Fig. 4) is likely to be due to the formation of 
covalently bonded oligomeric protein:RNA complexes. 
Fig. 2  Immunohistochemistry reveals the distribution of dipeptide 
repeat protein containing inclusions consisting of species derived 
from sense and antisense repeat RNAs in two neuronal populations. 
Representative images showing that poly-GA and poly-GR contain-
ing inclusions are more numerous in cerebellar granule neurons, 
whereas poly-PA and poly-PR containing inclusions are more numer-
ous in motor neurons. Staining was carried out individually for each 
protein (a) and then poly-GA and poly-PA were examined by dual 
staining (b). Inclusions are highlighted by arrowheads. Scale bar 
3 µm
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Table 3  Mean and standard 
deviation (SD) of number of 
inclusions per cell containing 
poly-GA and poly-PA protein, 
in granule neurons and motor 
neurons from six patients with 
C9ORF72-disease
In each case, poly-GA containing inclusions are significantly more numerous in granule neurons (likeli-
hood-ratio test p < 0.01) and poly-PA containing inclusions are significantly more numerous in motor neu-
rons (likelihood-ratio test p < 0.01)
Case Poly-PA (mean) Poly-PA (SD) Poly-GA (mean) Poly-GA (SD) p value
Motor neurons
 1 2.1 2.32 0 0 0
 2 2.4 3.58 0.5 0.76 1.57E−34
 4 2 1.83 0.3 0.35 0.0046
 6 1.2 0.75 0 0 1.55E−21
 7 1.7 1.56 0.2 0.40 0
 8 4.4 2.07 0.2 0.44 0
Granule neurons
 1 0.04 0.18 0.2 0.36 2.42E−44
 2 0.01 0.07 0.21 0.37 0
 4 0.04 0.2 0.2 0.42 0
 6 0.01 0.09 0.1 0.36 0
 7 0.01 0.08 0.1 0.29 7.58E−49
 8 0.01 0.12 0.1 0.34 0
Fig. 3  Combined RNA FISH and IHC demonstrate colocalisation of 
nucleolin and nuclear speckle components with antisense RNA foci in 
Purkinje neurons from C9ORF72-ALS patients and the distribution of 
these proteins in Purkinje neurons from control individuals. SRSF2 (a), 
hnRNP A1 (b), hnRNP H/F (c), ALYREF (d), and hnRNP K (e) are 
observed to colocalise with antisense RNA foci (arrows) in Purkinje neu-
rons from C9ORF72-ALS patients. A large scale view is shown to the 
left of a zoomed-in image. Colocalisation events are enlarged including 
orthogonal views, and unmerged protein and RNA foci are shown for 
comparison. There was not a significant difference between the staining 
of these proteins in controls and C9ORF72+ individuals, but no anti-
sense RNA foci are observed in controls. Nucleolin was not observed 
to colocalise with antisense RNA foci (f); moreover, the distribution of 
nucleolin was variable in C9ORF72+ Purkinje neurons. In some cells, 
nucleolin was prominently nucleolar (f, left panel) and in other cells it 
was dispersed throughout the nucleus (f, right panel, RNA focus is indi-
cated by an arrowhead). The dotted line illustrates the nuclear border in 
images a–e and the nucleolar border in image f. Scale bar 3 µm
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Multiple molecules of RRM-containing proteins bind to 
RNA oligonucleotides via inter and intra molecular inter-
actions. We have demonstrated a similar effect previously 
[10].
Cellular distribution of RNA foci and TDP‑43
We also examined the association of RNA foci with deple-
tion of TDP-43 from the nuclei of motor neurons of seven 
patients with C9ORF72-ALS. Nuclear depletion and cyto-
plasmic mislocalisation of TDP-43 form the pathological 
hallmark of most subtypes of ALS, including C9ORF72-
mediated disease [25]. We have previously shown that 
the proportion of sense RNA foci+ motor neurons with 
and without nuclear TDP-43 is approximately equiva-
lent (χ2, p = 0.75) [3]. As a direct comparison with this 
study, approximately fifty motor neurons were examined 
in FFPE sections from seven C9ORF72-ALS cases (Sup-
plementary Table 5). Unlike sense RNA foci, the presence 
of antisense foci was significantly associated with nuclear 
loss of TDP-43. Seventy-seven percent of antisense foci+ 
motor neurons displayed loss of nuclear TDP-43 compared 
to 13 % of motor neurons without observable antisense foci 
(χ2, p < 0.00001) (e.g. Fig. 5). A similar experiment in hip-
pocampal CA4 subfield neurons did not reveal a significant 
correlation between the presence of antisense foci and 
nuclear loss of TDP-43, indeed no CA4 subfield neurons 
exhibited complete nuclear clearance of TDP-43 (data not 
shown).
Discussion
The precise mechanisms of neuronal injury in C9ORF72-
disease appear complex, and are likely to involve RNA 
gain-of-function toxicity mediated by sense and antisense 
transcription of the GGGGCC repeat expansion (reviewed 
in [2, 4]). The small number of cases examined in this study 
and the wide variability in the phenotype of C9ORF72-
related disease prohibits informative comparison between 
foci distribution and clinical phenotype, but a useful proxy 
is the pathological hallmark of ALS neurodegeneration: 
nuclear loss of TDP-43 [25]. We have demonstrated that 
antisense but not sense foci are significantly associated 
with nuclear loss of TDP-43 in motor neurons. This intrigu-
ing observation suggests that antisense RNA foci may 
occupy a key position in the cascade of disease pathogen-
esis. Moreover, examining the differences and similarities 
between the two species of RNA foci may shed light on 
important mechanisms leading to neurodegeneration.
Fig. 3  continued
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We have demonstrated colocalisation of antisense RNA 
foci with SRSF2, hnRNP A1, hnRNP H/F, ALYREF, and 
hnRNP K, but not nucleolin. This is consistent with the 
work of Haeusler et al. [11]. UV-crosslinking studies con-
firmed that each of these interactions is direct and specific, 
with the exception of hnRNP K. Conflicting results between 
the two methodologies may arise because IHC is unable to 
distinguish between direct and indirect interaction. There is 
significant potential for indirect binding: many RRM pro-
teins co-exist and interact within nuclear speckles. Notably 
of the proteins we have examined, SRSF2 colocalisation 
with both sense [3] and antisense foci was observed with 
the highest frequency, and this protein is the core compo-
nent of nuclear speckles [30].
Both the IHC and the UV-crosslinking studies in this 
report suggest that the binding partners of sense and anti-
sense RNA foci are not significantly different. This is also 
reported by others [11]. Many of these identified binding 
partners are localised, with SRSF2, to nuclear speckles, 
nuclear domains implicated in the storage, and supply of 
splicing factors to active transcription sites [30]. Neuro-
muscular diseases, including type 1 myotonic dystrophy 
(DM1), have been associated with depletion of normal 
components of nuclear speckles [1, 29]. Sequestration of 
these proteins by sense or antisense RNA foci and conse-
quent disruption of the normal function of these essential 
nuclear organelles might be a key event in the pathophysi-
ology of C9ORF72-mediated neurodegeneration. If so, our 
results would predict that both species of RNA foci should 
be equally toxic. This is consistent with observed toxicity 
of sense foci in various model systems [8, 16, 17, 21, 28]. 
This led us to ask whether the key difference might not be 
in the interactions of the foci themselves, but in the neu-
ronal populations in which sense and antisense foci are 
expressed.
In all cases, the relative frequency of sense and antisense 
foci varied consistently and significantly between neuronal 
populations. Importantly in motor neurons, the primary tar-
get of pathology in ALS, antisense foci are more abundant 
than sense foci. Therefore, we suggest that the key event 
determining toxicity leading to TDP-43 mislocalisation, of 
antisense as opposed to sense RNA foci, might be a pro-
pensity to produce antisense foci mediated by cell-specific 
transcriptional regulation. Alternatively sense RNA foci 
Fig. 3  continued
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might be degraded at a higher rate than antisense RNA foci. 
In-vitro studies have suggested that both sense and anti-
sense RNA sequences form complex secondary structures 
including G-quadruplexes and hairpin loops [11]. These 
secondary structures may help stabilize the RNA foci and 
prevent degradation.
It is interesting that two populations of relatively large 
neurons, motor neurons and cerebellar Purkinje neu-
rons, exhibited antisense RNA foci at a higher frequency 
than sense RNA foci, in contrast to the smaller cerebel-
lar granule neurons. This suggests that our observations 
may be related to some property correlated with neuronal 
size. However, in the hippocampus, neither the larger CA4 
subfield neurons nor the smaller dentate granule neurons 
exhibited either species of RNA foci at a consistently 
higher frequency.
We observed antisense foci in the cytoplasm of motor 
neurons, which is consistent with aberrant nuclear export 
and may be a key step in the facilitation of proposed repeat 
associated non-ATG translation to produce DPR species 
[24]. We made a similar observation with respect to sense 
foci [3] and we suggest that interaction between repeat 
RNA and mRNA export adaptors, such as ALYREF, might 
override the normal nuclear retention of pre-mRNA spe-
cies. Recent studies consistent with a key role for DPRs in 
the pathogenesis of C9ORF72-mediated neurodegeneration 
[15, 20, 22] suggest that this represents an attractive thera-
peutic target.
We have demonstrated that the frequency of sense and 
antisense foci is usually correlated i.e. a patient with more 
sense foci will also have more antisense foci. This is par-
ticularly interesting in case 1 from our analysis (Table 2) 
who displayed a relatively high frequency of sense and 
antisense RNA foci in the cerebellum and CA4 subfield 
neurons of the hippocampus, which are both extra-motor 
areas. Case 8 also exhibited a relatively high frequency of 
sense and antisense RNA foci in CA4 subfield neurons; the 
frequency of RNA foci in the cerebellum of case 8 was not 
quantified. In contrast to the other cases examined these 
patients displayed extra-motor disease clinically as well 
as pathologically: clinical FTD was diagnosed with (case 
1) and without (case 8) ALS (Table 1). This is consistent 
with a correlation between the development of RNA foci 
in specific neuronal subtypes and clinical presentation, but 
this hypothesis will require validation in a larger number of 
FTD and ALS cases.
Fig. 4  Specific and direct interactions between (GGGGCC)5 and/
or (CCCCGG)5 and hnRNP A1, hnRNP F, SFRS2, and ALYREF but 
not hnRNP K or Magoh (negative control). Magoh, SRSF2 9-101, 
ALYREF, hnRNP A1-like2, hnRNP K, and hnRNP F were expressed 
in E. coli and purified (see Supplementary Table 4). (GGGGCC)5 
(sense) and (CCCCGG)5 (antisense) RNA oligonucleotides were 
end labelled with polynucleotide kinase using [ɣ-32P]-ATP, prior to 
incubation with purified proteins. RNA was covalently bound (+) or 
not (−) following UV irradiation. The absence of radioactive signal 
(right panel, PhosphoImage) in the absence of UV irradiation dem-
onstrates specificity of direct binding observed after UV treatment. 
All gels shown in the different panels were exposed simultaneously 
for the same amount of time (4 h). Note that a high molecular weight 
band is also observed for ALYREF due to oligomerisation properties 
[10]
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Finally, varying frequency of the expression of sense and 
antisense repeat RNA has implications for the formation of 
specific DPRs. Our observations of all five DPRs are consist-
ent with our conclusions relating to the expression of sense 
and antisense RNA foci. In cerebellar granule neurons, where 
sense RNA foci are more abundant, there is a higher frequency 
of sense-RNA derived DPR inclusions; and in motor neurons 
where antisense RNA foci are more abundant, there is a higher 
frequency of antisense RNA-derived DPR inclusions. There-
fore, we suggest that, at least in these neuronal populations, 
translation of the sense and antisense derived proteins occurs 
in different quantities depending of the relative availability 
of RNA repeat molecules. The results of the present study 
potentially explain the observations of others that inclusions 
containing poly-GA protein are much more abundant in cer-
tain neuronal populations including cerebellar granule neu-
rons [18]. However, Davidson et al. [6] failed to demonstrate 
antisense RNA derived DPR inclusions in Purkinje neurons 
of the cerebellum and dentate gyrus neurons of the hippocam-
pus. This contrasts with our demonstration of antisense RNA 
foci in both of these populations, particularly in the cerebel-
lar Purkinje neurons which we found to show a preference for 
exhibiting antisense rather than sense RNA foci. This variation 
between neuronal populations might be explained by vari-
ability in control of nuclear export of repeat RNA species; in 
this context, it is interesting that mutations in hGle1, a mRNA 
export adaptor, have recently been shown to cause selective 
death of motor neurons [14].
In our previous study we showed that there was no signifi-
cant correlation between the presence or absence of nuclear 
sense RNA foci in cerebellar granule neurons and whether 
or not those cells contain a cytoplasmic inclusion positive for 
poly-GA [3]. Similarly in this study we have shown that there 
is no significant correlation between the presence or absence 
of nuclear antisense RNA foci in motor neurons, and whether 
or not those cells contain an inclusion positive for poly-PA. 
This suggests that our population level conclusion in this 
study, that neuronal populations have a propensity to produce 
either sense or antisense RNA derived foci and DPRs, does 
not apply at a cellular level. Thus, whilst both RNA foci and 
DPRs are derived from the same RNA molecules, the pro-
cesses by which this RNA is stabilised into a focus or exported 
for translation are probably different or even mutually exclu-
sive—indeed work from Gendron et al. [9] suggested that this 
might be the case. So if motor neurons have a preference for 
antisense transcription of the C9ORF72 expansion then the 
Fig. 5  TDP-43 IHC and RNA FISH demonstrate that antisense RNA 
foci are significantly associated with nuclear clearance of TDP-43 in 
motor neurons. Representative images showing that antisense RNA 
foci (arrowheads) are significantly associated with nuclear clearance 
of TDP-43 in motor neurons of C9ORF72-ALS patients; split channel 
images are provided for comparison. Cleared TDP-43 may be present 
within a cytoplasmic inclusion (upper panels; RNA focus is indicated 
by the arrowhead, a compact inclusion is arrowed) or simply present 
in the cytoplasm (middle panels; RNA foci are indicated by arrow-
heads). In contrast, the absence of antisense RNA foci is significantly 
associated with the presence of nuclear TDP-43 (lower panels). Scale 
bar 3 µm
▸
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motor neuron population will express higher levels of anti-
sense RNA derived foci and DPRs, but not necessarily within 
the same individual cells.
Our work highlights that any therapeutic approach to 
C9ORF72-ALS should consider the presence of antisense RNA 
foci in motor neurons. An antisense oligonucleotide approach 
has been proposed as a therapeutic option in C9ORF72-disease 
[8, 28]. We suggest that both sense and antisense RNAs should 
be targeted, as has been proposed by others [16]. Indeed, in rela-
tion to the relative selective vulnerability of motor neurons in 
C9ORF72-mediated pathology in vivo, targeting the antisense 
foci may be even more important than targeting sense foci. A 
limitation of our study is the reliance on post-mortem tissue 
which represents end-stage disease and may exclude the most 
vulnerable cells which have already been lost; as such we await 
validation of our findings in model systems.
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